Citryll announces appointments of Eduardo Bravo as CEO and Tim Schenk as CBO

 TargED Biopharmaceuticals B.V., a clinical-stage biotechnology company developing next-generation targeted treatments for...

Phase I trial data in rheumatoid arthritis patients demonstrates favorable safety, encouraging clinical activity, and robust...

Quickborn, Germany and Eindhoven, Netherlands – September 24, 2025 - Mammotome, a globally recognized leader in breast care, and...

Randomized multi-center study designed to assess the efficacy, safety, and tolerability of CIT-013 in patients with moderately...

Utrecht, the Netherlands  TargED Biopharmaceuticals B.V., a pioneering Utrecht-based biotech company developing...

Avidicure CEO Arthur Lahr spoke with Nuala Moran of BioWorld News about their $50M seed funding and how AVC-Boosters are...